Capecitabine

• Capecitabine is an oral chemotherapy prodrug that specifically targets cancer cells.
• It works by converting into 5-fluorouracil (5-FU), which disrupts DNA and RNA synthesis in rapidly dividing tumor cells.
• Common indications include metastatic colorectal, adjuvant colorectal, metastatic breast, and advanced gastric cancers.
• Dosage and administration schedules are highly individualized and require strict adherence.
• Patients must be aware of potential side effects, such as hand-foot syndrome and myelosuppression, and report any concerns to their healthcare provider.

What is Capecitabine and How it Works

Capecitabine is an oral fluoropyrimidine carbamate that serves as a prodrug of 5-fluorouracil (5-FU), a well-established cytotoxic agent. It is designed for selective activation, with higher concentrations of the active chemotherapy agent being released within tumor cells compared to healthy tissues. This targeted approach aims to enhance efficacy while potentially reducing systemic toxicity.

The mechanism by which capecitabine works in the body involves a three-step enzymatic conversion process. Initially, capecitabine is converted to 5′-deoxy-5-fluorocytidine (5′-DFCR) in the liver by carboxylesterase. Subsequently, cytidine deaminase, an enzyme found in various tissues including the liver and tumors, transforms 5′-DFCR into 5′-deoxy-5-fluorouridine (5′-DFUR). The final and crucial step involves thymidine phosphorylase (TP), an enzyme often present at elevated levels in many types of tumors, which converts 5′-DFUR into the active compound, 5-fluorouracil (5-FU). Once formed, 5-FU interferes with the synthesis of both DNA and RNA, ultimately leading to cell death in rapidly proliferating cancer cells.

Capecitabine Uses and Administration

Capecitabine is primarily indicated for the treatment of several types of cancer. These include metastatic colorectal cancer, adjuvant colorectal cancer (after surgery to prevent recurrence), metastatic breast cancer, and advanced gastric cancer. It can be utilized as a standalone therapy or in combination with other chemotherapeutic agents and targeted treatments, depending on the specific cancer type, stage, and patient characteristics.

Regarding capecitabine medication information, the precise dosage and administration schedule are highly individualized, taking into account factors such as the specific cancer being treated, the patient’s body surface area, and their renal function. The medication is typically taken orally, usually twice daily, and should be ingested with food or within 30 minutes after a meal to optimize absorption and reduce gastrointestinal side effects. Treatment often follows cyclical regimens, such as two weeks of medication followed by a one-week rest period, allowing the body to recover. Patients receive comprehensive instructions from their healthcare team regarding their specific dosing regimen, and strict adherence to this schedule is vital for the medication’s effectiveness and to help manage potential adverse reactions. Regular monitoring of blood counts, liver function, and kidney function is essential throughout the treatment course.

Capecitabine Side Effects and Important Warnings

As with all chemotherapy agents, Capecitabine can cause a range of side effects, some of which may be severe. Patients must be vigilant and promptly report any new or worsening symptoms to their healthcare team. Understanding capecitabine side effects and warnings is crucial for safe and effective treatment.

• Common Side Effects:
  • Hand-foot syndrome (palmar-plantar erythrodysesthesia), characterized by redness, swelling, pain, and blistering on the palms and soles.
  • Diarrhea, which can sometimes be severe and lead to dehydration.
  • Nausea and vomiting.
  • Fatigue and weakness.
  • Stomatitis (mouth sores).
  • Abdominal pain.
• Important Warnings:
  • Myelosuppression: Capecitabine can suppress bone marrow activity, leading to reduced blood cell counts (anemia, neutropenia, thrombocytopenia), increasing risks of infection and bleeding.
  • Cardiotoxicity: Although less common, cardiac events such as angina, myocardial infarction, and arrhythmias have been reported, particularly in individuals with pre-existing heart conditions.
  • Dehydration and Electrolyte Imbalance: Severe diarrhea can result in significant fluid and electrolyte loss, necessitating medical intervention.
  • Drug Interactions: Capecitabine can interact with other medications, most notably warfarin, potentially increasing the risk of bleeding. Patients must inform their doctor about all medications, supplements, and herbal products they are taking.
  • Kidney and Liver Impairment: Dosage adjustments may be required for patients with impaired kidney or liver function, as these organs are critical for drug metabolism and excretion.
  • Pregnancy and Breastfeeding: Capecitabine is known to be harmful to a fetus and should not be used during pregnancy. Women of childbearing potential should use effective contraception during treatment and for a specified period afterward. Breastfeeding is also not recommended while undergoing treatment.